Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Oligo (dT) 25 Beads: Technical Guide for Eukaryotic mRNA Iso

    2026-06-28

    Oligo (dT) 25 Beads: Practical Use in Eukaryotic mRNA Isolation

    What This Product Solves

    Isolating high-integrity mRNA is a foundational step for transcriptomics, RT-PCR, and next-generation sequencing workflows. Total RNA samples from eukaryotic sources typically contain abundant ribosomal and other non-coding RNAs that can compromise downstream analyses. Oligo (dT) 25 Beads provide a solution by selectively capturing polyA-tailed mRNA using covalently bound oligo (dT) stretches on superparamagnetic beads. This targeted approach enables rapid, reproducible enrichment of eukaryotic mRNA, reducing background and supporting sensitive applications such as first-strand cDNA synthesis or RT-PCR. Unlike precipitation or column-based kits, these beads allow direct, gentle mRNA purification from total RNA or lysed cells, minimalizing RNA degradation and improving yield and purity. Applications include but are not limited to library construction, ribonuclease protection assays, and Northern blots. These beads are not suitable for prokaryotic samples or for capturing non-polyadenylated transcripts.

    For a scenario-driven overview on best practices, see the internal article Enhancing Eukaryotic mRNA Isolation: Scenario-Driven Insights, which details troubleshooting and protocol optimization with APExBIO beads. Additionally, the article Oligo (dT) 25 Beads: Practical Guide for Eukaryotic mRNA Isolation outlines core workflow steps and limitations for researchers seeking a concise procedural reference.

    Protocol Parameters

    • Bead Concentration: 10 mg/mL | Used per manufacturer's instructions for mRNA capture | Directly applies to preparation of bead suspension prior to binding | Ensures sufficient binding capacity and consistency across batches | product dossier
    • Sample Input Type: Total RNA or lysed eukaryotic cells/tissues | Use with animal or plant samples only | Non-eukaryotic or non-polyA RNA will not be captured | The oligo (dT) surface chemistry is specific for polyadenylated mRNA | product dossier
    • Storage Conditions: 4 °C, do not freeze | Store for 12–18 months | Maintains bead integrity and binding performance | Freezing can aggregate or damage beads, reducing efficacy | product dossier
    • Binding Temperature: Room temperature (recommended: 20–25 °C) | Applies during hybridization step | Promotes optimal oligo (dT)/polyA base pairing | Lower or higher temperatures may reduce binding efficiency | workflow recommendation
    • Washing Buffer: Low-salt, RNase-free buffer | Use for stringent washes post-binding | Minimizes rRNA and DNA carryover | High ionic strength buffers may disrupt mRNA-oligo (dT) interactions | workflow recommendation
    • Elution Volume: 10–50 µL RNase-free water or low-salt buffer | Adjust based on downstream assay | Smaller volumes yield higher mRNA concentration | Excessive dilution may impede sensitivity in downstream applications | workflow recommendation

    Workflow Setup and QC Checklist

    1. Sample Preparation: Begin with high-quality, DNase-treated total RNA or freshly lysed eukaryotic cells/tissues. Avoid freeze-thaw cycles to prevent RNA degradation.
    2. Bead Handling: Vortex or gently invert the bead suspension before aliquoting to ensure homogenous distribution. Do not allow beads to dry at any step.
    3. Hybridization Step: Incubate beads with RNA sample at room temperature with gentle mixing for 10–30 minutes, optimizing time based on sample complexity and input amount.
    4. Magnetic Separation: Use a suitable magnetic rack for separation. Carefully remove supernatant without disturbing the pellet.
    5. Wash Steps: Perform at least two washes with RNase-free, low-salt buffer. Increase wash stringency if background contamination persists.
    6. Elution: Elute captured mRNA in RNase-free water or low-salt buffer. Briefly heat (e.g., 65 °C for 2–5 min) if gentle elution is insufficient, then promptly cool on ice.
    7. Quality Control: Assess mRNA integrity via capillary electrophoresis or agarose gel. Quantify yield spectrophotometrically or with fluorometric RNA assays. If using as first-strand cDNA synthesis primer, proceed directly; otherwise, check for bead carryover before downstream applications.

    Common Failure Modes and Fixes

    • Low mRNA Yield: May result from insufficient bead resuspension, degraded input RNA, or suboptimal binding/wash conditions. Confirm bead homogeneity, input RNA quality, and adjust hybridization time or buffer conditions as needed.
    • Genomic DNA or rRNA Contamination: Indicates incomplete wash or insufficient stringency. Increase number of washes or adjust buffer composition to reduce carryover. Consider additional DNase treatment prior to mRNA capture.
    • Bead Loss During Washing: Occurs if magnetic separation is incomplete or beads are aspirated with supernatant. Use an appropriate magnetic rack and pipette carefully along the tube wall.
    • Poor Downstream Performance: If RT-PCR or cDNA synthesis efficiency is low, verify that elution buffer is compatible with downstream enzymes, and confirm absence of residual inhibitors or ethanol from preceding steps.
    • Bead Aggregation: Can result from freezing or improper storage. Always store beads at 4 °C, avoid freezing, and resuspend thoroughly prior to use.

    Scope and Limitations

    Oligo (dT) 25 Beads are intended solely for the isolation of polyadenylated mRNA from eukaryotic sources. The technology is not suitable for prokaryotic RNA, non-polyA transcripts, or workflows requiring capture of small RNAs or total RNA. Performance depends on input RNA integrity and the absence of RNases. The beads' oligo (dT) moiety can serve directly as a primer for first-strand cDNA synthesis, but if eluted, ensure complete bead removal prior to sensitive downstream reactions. Store at 4 °C and avoid repeated temperature fluctuations to preserve bead functionality for up to 18 months as specified in the product dossier. For an expanded guide on workflow scenarios and troubleshooting, refer to the internal article "Enhancing Eukaryotic mRNA Isolation: Scenario-Driven Insights."

    Conclusion

    Oligo (dT) 25 Beads deliver reliable, targeted eukaryotic mRNA isolation by leveraging superparamagnetic beads functionalized with covalently bound oligo (dT) sequences. When handled according to manufacturer and workflow best practices, these beads support consistent RNA yields and purity for RT-PCR, cDNA library construction, and other molecular biology applications. Use within the outlined scope for optimal results, and consult APExBIO's product documentation for updates on storage or handling recommendations.